Sign In

Arsani William, MD

Biotech Investor

Arsani William, MD is the Managing Partner and Chief Investment Officer of Logos Capital, a global life science investment fund he founded in 2019.12 Dr. William holds an MD from Harvard Medical School, where he was a Gerald S. Foster Scholar, an MBA from Stanford's Graduate School of Business, and a BS with Honors in Biology from Stanford University.14

Before founding Logos Capital, Dr. William was an investment professional at Farallon Capital Management, where he contributed to the growth of Farallon's biopharma portfolio.2 His expertise lies in healthcare and biotechnology investments, with a focus on identifying and funding transformative therapies.13

Dr. William currently serves on the board of Design Therapeutics (NASDAQ: DSGN) and is a board observer at Odyssey Therapeutics.24 He has been recognized as a Forbes 30 Under 30 in Healthcare and has published research in prestigious journals.56

Logos Capital, under Dr. William's leadership, manages discretionary assets totaling over $1.5 billion as of April 2024.1 The firm specializes in both private and public therapeutic innovation, employing a data-driven approach to identify promising investments in the biotechnology sector.3

Related Questions

What are some of the key investments made by Logos Capital under Dr. William's leadership?
How does Logos Capital's approach to biotechnology investing differ from other firms?
What is the significance of Dr. William's background in medicine for his investment strategy?
Can you provide examples of companies that have benefited from Logos Capital's investments?
How does Logos Capital's data analytics platform enhance their investment decisions?
Arsani William, MD
Arsani William, MD, photo 1
Arsani William, MD, photo 2
Add to my network

Location

San Francisco, California, United States

Related People

Related people

Related People

Related people